7Baggers
 Stocks With Rising Relative Strength: Immunocore Holdings ADR  Investor's Business Daily Tue, 11 Nov 2025 08:00:00 GMT
 Immunocore to present at upcoming investor conferences  Investing News Network Mon, 10 Nov 2025 12:59:12 GMT
 Immunocore Reports Strong Growth in Q3 2025  The Globe and Mail Sat, 08 Nov 2025 06:28:47 GMT
 immunocore (imcr) reports promising phase 1 trial results for im  GuruFocus Fri, 07 Nov 2025 13:44:06 GMT
 Immunocore reports promising data for HBV treatment candidate  Investing.com Fri, 07 Nov 2025 13:11:12 GMT
 immunocore reports strong growth in q3 2025  TipRanks Fri, 07 Nov 2025 05:25:01 GMT
 Decoding Immunocore Holdings PLC (IMCR): A Strategic SWOT Insigh  GuruFocus Fri, 07 Nov 2025 05:18:48 GMT
 discipline and rules-based execution in imcr response  news.stocktradersdaily.com Fri, 07 Nov 2025 00:56:02 GMT
 immunocore reports q3 eps 0c, consensus (24c)  TipRanks Thu, 06 Nov 2025 13:08:25 GMT
 Immunocore Holdings PLC Q3 2025 Earnings: EPS of ($0.00) Beats E  GuruFocus Thu, 06 Nov 2025 12:56:15 GMT
 Immunocore (IMCR) Surpasses Revenue Expectations in Q3  GuruFocus Thu, 06 Nov 2025 12:56:08 GMT
 Immunocore Holdings plc SEC 10-Q Report  TradingView Thu, 06 Nov 2025 12:03:00 GMT
 Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to Say  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Immunocore Reports Strong Growth in Q3 2025  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 immunocore to present at upcoming investor conferences  富途牛牛 Sun, 02 Nov 2025 07:00:00 GMT
 wells fargo initiates coverage on immunocore holdings (imcr) wit  GuruFocus Sat, 01 Nov 2025 06:40:01 GMT
 Wells Fargo Initiates Coverage on Immunocore Holdings (IMCR) wit  GuruFocus Fri, 31 Oct 2025 21:34:21 GMT
 immunocore initiated with an overweight at wells fargo  TipRanks Fri, 31 Oct 2025 10:51:14 GMT
 wells fargo initiates immunocore at overweight with $60 price target  MarketScreener Fri, 31 Oct 2025 07:00:00 GMT
 TANG CAPITAL MANAGEMENT LLC Increases Stake in Immunocore Holdin  GuruFocus Fri, 31 Oct 2025 00:48:08 GMT

Immunocore Holdings plc
(NASDAQ:IMCR) 

IMCR stock logo

Immunocore Holdings plc, a late-stage biotechnology company, develops immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. The company's lead oncology therapeutic candidate is tebentafusp, which is in a randomized Phase 3 clinical trial in patients with previously untr...

Founded: 2008
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends